[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work With Us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Academy Training
  • Bespoke Training
  • Making Pharmaceuticals Show
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
Is your scope of Wholesale Distribution Authorisation (WDA) out of date?

Is your scope of Wholesale Distribution Authorisation (WDA) out of date?

by Kimberley Peck | Aug 23, 2022 | Blog, MHRA, WDA(H)

Is your scope of Wholesale Distribution Authorisation (WDA) out of date? – Are you aware that the Wholesale Distribution Authorisation (WDA) categories have changed?

Separation of the Licence Holder and Responsible Person

Separation of the Licence Holder and Responsible Person

by Steven Hewison | Aug 23, 2022 | Blog, MHRA

Separation of the Licence Holder and Responsible Person – The last paragraph on page 128 of the 2017 Green Guide contained the following sentence:

In the case of small companies, the licensing authority may accept the licence holder as the nominated RP.

Defective Medicinal Products and Recall Management Guidance

Defective Medicinal Products and Recall Management Guidance

by Amelia Holmes | Aug 5, 2022 | Blog, MHRA

The main concerns with regard to possible defects of medicinal products and the substances used in their manufacture or packaging.

Medicinal products seized by MHRA worth just under £1,000,000

Medicinal products seized by MHRA worth just under £1,000,000

by Thomas Currie | Jul 28, 2022 | Blog, MHRA

Medicinal products seized within the week running from the 23rd-30th June, the Medicines and Healthcare products Regulatory Agency (MHRA) seized 285,000 medicines and medical devices which were valued at almost £1,000,000.

Import Licensed Human Medicine(s) to the United Kingdom (UK) – Guidance

Import Licensed Human Medicine(s) to the United Kingdom (UK) – Guidance

by Amelia Holmes | Jul 13, 2022 | Blog, MHRA, WDA(H), WDA(H)

Import Licensed Human Medicine – Prior to importation of a licensed medicine applications for the relevant Licence(s) must be completed and submitted which may include one or more of the following:

Import Unlicensed Human Medicine(s) to the United Kingdom (UK) – guidance

Import Unlicensed Human Medicine(s) to the United Kingdom (UK) – guidance

by Amelia Holmes | Jul 13, 2022 | Blog, Good Distribution Practice - GDP, MHRA, WDA(H)

An Introduced Product is an unlicensed medicine which can be imported from a country other than an approved country for import to be exported to a country other than an approved country for import, or if imported from a non-EEA country into Northern Ireland for export back to a country outside the EEA.

« Older Entries
Next Entries »

Recent Posts

  • MHRA-NICE aligned pathway
  • New regulations for clinical trials
  • Pharmacy Consulting Ltd – Audit Training

Upcoming Courses

  • GDP/RP Cogent Gold Standard Online Training on 14 April 2026
  • Active Pharmaceutical Ingredient (API) and Clinical Trials Online Training on 27 April 2026 2:00 pm
  • Introduction to Good Distribution Practice Online Training on 13 May 2026 10:00 am
  • Superintendent Pharmacist training (Online) on 14 May 2026
  • GDP/RP Cogent Gold Standard Online Training on 19 May 2026

MHRA Alerts & Recalls

Field Safety Notices: 30 March - 3 April 2026
8 April 2026
MHRA Safety Roundup: March 2026
31 March 2026
Field Safety Notices: 23-27 March 2026
31 March 2026
Class 2 Medicines Recall: Bio Products Laboratory Limited, Rabies, Human normal Immunoglobulin 500IU solution for Injection, EL(26)A/18
30 March 2026

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow